Evolus Inc (NASDAQ:EOLS)

8.59
Delayed Data
As of Feb 28
 +0.06 / +0.70%
Today’s Change
8.28
Today|||52-Week Range
29.50
-29.42%
Year-to-Date
Evolus, Inc. (EOLS) Q4 2019 Earnings Call Transcript
Feb 25 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close8.53
Today’s open8.33
Day’s range8.28 - 8.73
Volume738,194
Average volume (3 months)627,774
Market cap$333.6M
Data as of 02/28/2020

Growth & Valuation

Earnings growth (last year)-611.33%
Earnings growth (this year)-60.36%
Earnings growth (next 5 years)+37.75%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.29

Competitors

 Today’s
change
Today’s
% change
STMLStemline Therapeutic...+0.23+3.97%
TCRRTCR2 Therapeutics In...-0.29-2.38%
LXRXLexicon Pharmaceutic...+0.00+0.18%
NERVMinerva Neuroscience...+0.10+1.39%
Data as of 02/28/2020

Financials

Next reporting dateMay 7, 2020
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$0.00
Annual profit (last year)-$46.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Newport Beach, California

Forecasts